Chen, Anan
Yu, Zhiwu
Ma, Na
Lu, Xinyu
Zhang, Yajing
Xu, Weikang
Wang, Yiyue
Xie, Jiayi
Qin, Yuqi
Mo, Guoheng
Wu, Sha
Hou, Jinlin
Zhu, Wei
Article History
Received: 15 November 2023
Accepted: 6 January 2024
First Online: 13 February 2024
Declarations
:
: The authors declare no competing interests.
: The authors have no relevant financial or non-financial interests to disclose.
: All mice studies were conducted in accordance with the local guidelines by Biocytogen and ethical approval was provided by Institutional Animal Care and Use Committee (IACUC) of China (AUP No: IACUC-LAC-20230919–001).
: Cancer Immunology, Immunotherapy (submitted in 2023) – Anan Chen et al.